The Ambry Classifi™️ Program is committed to providing the right answer, the first time. Our variant classification team leverages the best of both people and process to ensure an advanced scientific approach. Hear more from Dr. Rhonda Lassiter, leader of the Genomic Science Development Program at Ambry. Learn more and watch the full video here: https://hubs.ly/Q02FHmXW0
Ambry Genetics’ Post
More Relevant Posts
-
Mapping variant effects for a healthier future! Explore the Atlas of Variant Effects Alliance's 2023 Annual Report. From membership growth to global collaborations, discover how we're advancing genomics and making a difference. https://lnkd.in/gxweq3wq
-
-
I help benefit professionals stay a step ahead of the competition with the 3x3x3 Challenge.
Explore the LATEST 3x3x3 Challenges like this one on Fore Genomics and make sure to check out the most watched 3x3x3 Challenges for July 2024 at BenefitsAlly.com!
-
Tune in next week to learn about the latest from Claret!
Join us on August 22nd at 10 AM PST for the Serious Talk-7 webinar featuring Claret’s very own Chief Science Officer, Chris Troll! Mark your calendar: https://lnkd.in/eFtgHkSc In this session, Dr. Troll will cover the challenges of generating NGS libraries from #FFPE samples and explore how ClaretBio's enzymatic shearing module, #ForShear™, can be incorporated to improve your results. Don’t miss out on this insightful discussion!
-
-
Explore the LATEST 3x3x3 Challenges like this one on Fore Genomics and make sure to check out the most watched 3x3x3 Challenges for July 2024 at BenefitsAlly.com!
-
Roman Ortega Bianchi, Head Of BD & Commercial Strategy, Stämm Contributed an article "A Single Omic Falls Short For Understanding Life." "A new field of opportunity is created due to Multi-Omics analysis platforms, increasing the speed and amount of data analysis. Many laboratories can benefit from this type of advance to generate more discoveries and speed up decision-making in trials." says Roman Ortega Bianchi. The article will also be featured in the forthcoming special print edition on Genomics 2024. Read More : https://lnkd.in/g56pn6jV #genomicsrevolution #personalizedmedicine #bioengineeringaccessibility
-
-
DISGENET — our gene-disease association knowledge platform — was created in 2010. The need for reliable, high-quality genomics data hasn’t faltered, but the way we access data has vastly changed. Which is why the DISGENET platform has undergone a rebrand. We are proud to share the meaning behind our new logo ✨ The DISGENET logo features an elegant “s” shape, reflecting how we support you in transforming complex data into easy-to-understand insights inside our platform. It mirrors our heritage in genomics too, resembling a DNA strand 🧬 What do you think? 👉🏼 Follow DISGENET to learn more about the world’s most extensive and reliable gene-disease association network.
-
-
We’ve got 22 questions to challenge your knowledge of miRNA, from its discovery and biology to miRNA research methods. Answer 7 correctly, and you could win a QIAGEN notebook. Take the quiz now! ✅ https://lnkd.in/gEDfPpGw
